Form D Explorer

Source evidence

NextPoint Therapeutics, Inc. · 0001959209-26-000002

D filed July 30, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
CAMBRIDGE
street1
238 MAIN STREET
zipCode
02142
entityName
NextPoint Therapeutics, Inc.
entityType
Corporation
stateOrCountry
MA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold33728772number33728772/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount48729165number48729165/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count15number15/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 13d707339f087fe952d6a53ccabc93058dc05ecc24b44664581c195de78202d9. This proves extraction identity, not the accuracy of the filer's claims.